Search

everythinglearnresearchcommunity

for

Search:↓

Guaraná extract effectively reduces oiliness in skin and hair without harming skin health.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Nutrients and hormones affect root hair growth, but more research is needed to understand the genetic mechanisms.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Biotinidase deficiency can cause symptoms like sleepiness, hair loss, and seizures.

The new formulation greatly improved quercetin absorption in rats.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.

Polydopamine and quercetin together can speed up hair regrowth.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

TQC shows promise for better hair regrowth in treating hair loss.

KRDQN effectively predicts adverse drug reactions with high accuracy and clear explanations.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

QR678 Neo® is a safe and effective treatment for hair loss in men and women.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Computational techniques can improve drug development for treating certain conditions.

The DLQI is a key tool for measuring quality of life in dermatology.

The neighborhood face index (NFI) accurately predicts properties of complex molecules.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

QR 678 and QR 678 Neo are safe and promote hair growth, potentially helping chemotherapy-induced hair loss.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.